60.World Health Organization. Global hepatitis report, 2017 [homepage on the Internet]. Geneva: World Health Organization, 2017; p. 62. Available from: [ Links ]61.Beletsky L, Agrawal A, Moreau B, Kumar J, Weiss-Laxer N, Heimer R. Can Police training help align law enforcement and HIV prevention ? Preliminary evidence from the field. Am J Public Health. 2011;101(11):2012-2015. [ Links ]62.Cepeda JA, Beletsky L, Sawyer A, et al. Occupational safety in the age of the opioid crisis: Needle stick injury among Baltimore Police. J Urban Heal. 2017;94(March 2012):100-103. -016-0115-0 [ Links ]63.Davis CS, Johnston J, Zerden LDS, Clark K, Castillo T, Childs R. Attitudes of North Carolina law enforcement officers toward syringe decriminalization. Drug Alcohol Depend. 2014;1(144):265-269. [ Links ]64.Fernandes RM, Cary M, Duarte G, et al. Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews. BMC Public Health. 2017;17(1):1-15. -017-4210-2 [ Links ]65.De Montigny L, Vernez Moudon A, Leigh B, Young K. Assessing a drop box programme: A spatial analysis of discarded needles. Int J Drug Policy [serial online]. 2010 May;21(3):208-214. Available from: [ Links ]66.Klein SJ, Candelas AR, Cooper JG, et al. Increasing safe syringe collection sites in New York State. Public Health Rep [serial online]. 2008 Jul;123(4):433-440. Available from: [ Links ]67.Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Heal [serial online]. 2010 Jul 5;87(4):534-542. Available from: -010-9468-y [ Links ]68.Tookes HE, Kral AH, Wenger LD, et al. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Drug Alcohol Depend [serial online]. 2012 Jun;123(1-3):255-259. Available from: [ Links ]69.Aitken C, Moore D, Higgs P, Kelsall J, Kerger M. The impact of a police crackdown on a street drug scene: Evidence from the street. Int J Drug Policy. 2002;13:189-198. -3959(02)00075-0 [ Links ]70.Luisa Mittal M, Beletsky L, Patiño E, et al. Prevalence and correlates of needle-stick injuries among active duty police officers in Tijuana, Mexico. J Int AIDS Soc [serial online]. 2016;19(4 (Suppl 3)):1-7. Available from: [ Links ]71.Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet [serial online]. 2010 Jul 24 [cited 2012 Mar 9];376(9737):268-284. Available from: [ Links ]72.Latypov A, Bidordinova A, Khachatrian A. Opioid substitution therapy in Eurasia: How to increase the access and improve the quality. IDPC Briefing Paper. London: International Drug Policy Consortium, 2012; p. 1-19. [ Links ]
SMS Enabler 2.7.2 With Full Crack
86.Ford C. Guidance for working with cocaine and crack users in primary care [homepage on the Internet]. London: Royal College of General Practitioners, 2004; p. 39. Available from: www.smmgp.co.uk [ Links ]87.Petry NM, Stitzer ML. Contingency management: Using motivational incentives to improve drug abuse treatment. Yale Univ Psychother Dev Cent Train Ser. 2002;(6):1-55. [ Links ]
105.Drug Policy Alliance. Drug decriminalization in portugal learning from a health and human-centered approach [homepage on the Internet]. New York, NY: Drug Policy Alliance; 2018. Available from: www.drugpolicy.org3 [ Links ]106.Alliance for Healthier Communities. Safe supply. Harm reduction. 2020 Oct 8. Available from: -Reduction [ Links ]107.Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911-921. [ Links ]108.Bungay V, Johnson JL, Varcoe C, Boyd S. Women's health and use of crack cocaine in context: Structural and 'everyday' violence. Int J Drug Policy. 2010;21(4):321-329. [ Links ]109.Poole N, Urquhart C, Talbot C. Women-centred harm reduction reducing harms across social determinants of women' s health [homepage on the Internet]. Vancouver: British Columbia Centre of Excellence for Women's Health; 2010. Available from: -resources/documents/GenderingNatFrameworkWomencentredHarmReduction.pdf [ Links ]110.International HIV/AIDS Alliance, Harm Reduction International, Youth RISE. Tool for harm reduction service providers preparing for work with children and young people who inject. London: International HIV/AIDS Alliance; 2015. [ Links ]
Optimal dosing is important for full benefits of opioid substitution therapy (OST) to be realised. Opioid substitution therapy should be used for as long as a patient requires it (at minimum, 1 year). The risk of other opioid use is decreased with longer duration of OST.
2ff7e9595c
Comments